Vecuronium Bromide Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-475

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 67457-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

10 mg Carton (Image 02)

10 mg Carton (Image 02)
This appears to be a collection of text snippets from different sources, including drug labels and identification codes. It is not clear what the overall context or purpose is, but it seems to relate to the medication Vecuronium Bromide, which is available as a lyophilized powder for IV injection in single-dose vials. The text includes warnings about the drug being a paralyzing agent and instructions for use. However, there isn't enough information to provide a more detailed or meaningful description.*
FDA Label Image

20 mg Carton (Image 03)

20 mg Carton (Image 03)
This is the drug label for Vecuronium Bromide, an injectable medication sold under the NDC 67457-475-20. This medication is a paralyzing agent, and its Lyophilized Powder form is intended for IV Single Dose Only. Once reconstituted to a volume of 20 mL, it contains 1 mg/mL of Vecuronium Bromide. The medication should be used with caution, and only under the supervision of qualified medical personnel.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.